Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00141570 · ClinicalTrials.gov registry record · Phase 2

Study of the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal Women

A Phase 2 study of Menopause, sponsored by Solvay Pharmaceuticals.

Completed
Registry status
Phase 2
Development phase
350
Enrollment target
20
Study locations

NCT00141570 is a Phase 2 study of Menopause that has completed, run by Solvay Pharmaceuticals. The registered enrollment target is 350 participants, below the 9,388-participant average among 54 other Menopause trials with a reported enrollment target (96% lower). The trial reports 20 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00141570, a Phase 2 study of Menopause, has completed, sponsored by Solvay Pharmaceuticals.

COMPLETED
Registry status
Phase 2
Development phase
350 participants
Enrollment target
20
Study locations

Study Summary

To determine whether treatment with ESTRATEST® H.S. Tablets is superior to treatment with esterified estrogens tablets

Conditions Studied

Menopause

Interventions

  • DRUG esterified estrogens 0.625 mg and methyltestosterone 1.25 mg

Study Locations (20)

California

  • Site 68 - Carmichael
  • Site 55 - Encinitas
  • Site 6 - San Diego
  • Site 45 - Santa Rosa
  • Site 25 - Walnut Creek

Connecticut

  • Site 1 - Groton
  • Site 54 - Hartford
  • Site 30 - Trumbull
  • Site 34 - Waterbury

Alabama

  • Site 66 - Huntsville
  • Site 57 - Mobile
  • Site 46 - Montgomery

Florida

  • Site 10 - Aventura
  • Site 73 - Fort Myers
  • Site 51 - Leesburg

Arizona

  • Site 29 - Phoenix
  • Site 15 - Tucson

Arkansas

  • Site 3 - Jonesboro
  • Site 22 - Little Rock

Colorado

  • Site 26 - Denver

Trial Details

FieldValue
Enrollment Target 350 participants
Start Date 2004-06
Est. Completion 2007-06
Phase Phase 2

Sponsor

Solvay Pharmaceuticals

35 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00141570

The ClinicalTrials.gov registry entry for NCT00141570 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 9,388-participant average among 54 other Menopause trials with a reported enrollment target (96% lower). The listed sponsor is Solvay Pharmaceuticals, which has 35 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Menopause appearing as the primary indexed condition, and to 1 intervention - of which esterified estrogens 0.625 mg and methyltestosterone 1.25 mg is the first listed.

NCT00141570 reports 20 study locations spanning 7 distinct geographic areas - top geographies include California, Connecticut, Alabama.

Frequently Asked Questions

What is clinical trial NCT00141570 about?

NCT00141570 is a clinical study titled "Study of the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal Women". To determine whether treatment with ESTRATEST® H.S. Tablets is superior to treatment with esterified estrogens tablets

What is the current status of trial NCT00141570?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 350 participants. The study started on 2004-06. Estimated completion is 2007-06.

What conditions does trial NCT00141570 study?

This clinical trial studies the following conditions: Menopause.

What interventions are being tested in trial NCT00141570?

The interventions under investigation include: esterified estrogens 0.625 mg and methyltestosterone 1.25 mg (DRUG).

Who is sponsoring clinical trial NCT00141570?

This trial is sponsored by Solvay Pharmaceuticals, which has 35 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00141570 being conducted?

This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Menopause

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Menopause

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.